Morie Gertz, MD, Mayo Clinic, Rochester, 2019 Ed Forum
Teaches us about the incidence rates of WM, prevalence of IgM MGUS and smoldering WM, how MYD88 and CXCR4 impact outcomes in WM, MYD88 and transformation risk, hyperviscosity and when therapy is required, how WM affects the kidney (including amyloidosis), chemotherapy treatment of WM, how long responses last until new therapy is required, and strategies to monitor and manage adverse events associated with novel therapies for WM
Morie Gertz, MD, MACP – Mayo Clinic Rochester, 2018 Ed Forum
Discusses amyloidosis, MGUS neuropathy, cold agglutinin, cryoglobulinemia, large cell transformation, central nervous system in WM (Bing Neel), and MGRS (monoclonal gammopathy of renal significance)
Morie Gertz, MD, FACP – Mayo Clinic Rochester, 2017 Ed Forum
Raises questions and answers about WM, such as, “Are my kids going to get this? How long will I live? What can I do to live longer?” just to name a few
Morie Gertz, MD, MACP – Mayo Clinic, Rochester, 2015 Ed Forum
Dr. Gertz talks about the Mayo Clinic approach to treating WM patients and the impact that IWMF funding for research has had on the search for improved treatments and a cure for WM
Dr. Morie Gertz – Mayo Clinic, Rochester, 2015 Ed Forum
An informative analogy of the person as a garden and the weeds as cancer cells with suggestions to prevent growth of cancer cells.
Morie Gertz, MD – Mayo Clinic, Rochester, 2014 Ed Forum
Raises questions and answers about WM, such as, “Are my kids going to get this? How long will I live? What can I do to live longer?” just to name a few.
